Medical Care
Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Research Report 2025
- Mar 11, 25
- ID: 117561
- Pages: 92
- Figures: 95
- Views: 1
The global market for Isothermal Nucleic Acid Amplification Technology (INAAT) was valued at US$ 7109 million in the year 2024 and is projected to reach a revised size of US$ 12650 million by 2031, growing at a CAGR of 8.7% during the forecast period.
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
Market Driver:
The Isothermal Nucleic Acid Amplification Technology (INAAT) market is driven by the growing demand for rapid and accurate diagnostic tools for infectious diseases, genetic disorders, and cancer. INAAT's ability to deliver high sensitivity and specificity without the need for complex thermal cycling equipment makes it ideal for point-of-care testing and use in resource-limited settings. Additionally, the rise in global health concerns, such as pandemics, has increased the adoption of INAAT for quick and reliable pathogen detection.
Market Challenge:
A significant challenge in the INAAT market is the high cost of specialized reagents and kits, which can limit accessibility in developing regions. The technology's complexity and the need for skilled personnel to interpret results may hinder widespread adoption in low-resource settings. Moreover, competition from established technologies like PCR and emerging alternatives creates pressure for differentiation and cost-effectiveness.
Industry Trends:
The INAAT industry is witnessing advancements in portable and user-friendly diagnostic devices, enabling real-time testing in non-laboratory environments. Integration with microfluidics and smartphone-based detection systems is enhancing accessibility and convenience. There is also a growing focus on multiplex INAAT assays capable of detecting multiple targets simultaneously, increasing diagnostic efficiency. Collaborations between biotech firms and healthcare organizations are fostering innovation and expanding the application of INAAT in personalized medicine and global health initiatives.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
This report aims to provide a comprehensive presentation of the global market for Isothermal Nucleic Acid Amplification Technology (INAAT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology (INAAT).
The Isothermal Nucleic Acid Amplification Technology (INAAT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Isothermal Nucleic Acid Amplification Technology (INAAT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isothermal Nucleic Acid Amplification Technology (INAAT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies
Thermo Fisher Scientific
MeG Biotech
BioLabs
Mast Group
Segment by Type
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Segment by Application
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The isothermal nucleic acid amplification technology (INAAT) is used in molecular biology and recombinant DNA technologies for detecting and identifying nucleic acids. It is commonly used to amplify nucleic acids at a constant temperature, thereby eliminating the need for thermocycler equipment. Isothermal amplification of nucleic acids is a simple process that rapidly and efficiently accumulates nucleic acid sequences at constant temperature.
Market Driver:
The Isothermal Nucleic Acid Amplification Technology (INAAT) market is driven by the growing demand for rapid and accurate diagnostic tools for infectious diseases, genetic disorders, and cancer. INAAT's ability to deliver high sensitivity and specificity without the need for complex thermal cycling equipment makes it ideal for point-of-care testing and use in resource-limited settings. Additionally, the rise in global health concerns, such as pandemics, has increased the adoption of INAAT for quick and reliable pathogen detection.
Market Challenge:
A significant challenge in the INAAT market is the high cost of specialized reagents and kits, which can limit accessibility in developing regions. The technology's complexity and the need for skilled personnel to interpret results may hinder widespread adoption in low-resource settings. Moreover, competition from established technologies like PCR and emerging alternatives creates pressure for differentiation and cost-effectiveness.
Industry Trends:
The INAAT industry is witnessing advancements in portable and user-friendly diagnostic devices, enabling real-time testing in non-laboratory environments. Integration with microfluidics and smartphone-based detection systems is enhancing accessibility and convenience. There is also a growing focus on multiplex INAAT assays capable of detecting multiple targets simultaneously, increasing diagnostic efficiency. Collaborations between biotech firms and healthcare organizations are fostering innovation and expanding the application of INAAT in personalized medicine and global health initiatives.
Global key players of Isothermal Nucleic Acid Amplification Technology (INAAT) include Abbott, BioMerieux and Hologic, etc. Global top three manufacturers hold a share over 70%. North America is the largest market of Isothermal Nucleic Acid Amplification Technology (INAAT), with a share nearly 80%, followed by Europe.
This report aims to provide a comprehensive presentation of the global market for Isothermal Nucleic Acid Amplification Technology (INAAT), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Isothermal Nucleic Acid Amplification Technology (INAAT).
The Isothermal Nucleic Acid Amplification Technology (INAAT) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Isothermal Nucleic Acid Amplification Technology (INAAT) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Isothermal Nucleic Acid Amplification Technology (INAAT) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Abbott
BioMerieux
Hologic
BD
Grifols
Quidel
Meridian Bioscience
Qiagen
Eiken Chemical
OptiGene
HiberGene Diagnostic
Lucigen
Nippon Gene
Mast Group
New England Biolabs
Ustar Biotechnologies
Thermo Fisher Scientific
MeG Biotech
BioLabs
Mast Group
Segment by Type
LAMP
TMA
NEAR
NASBA
HDA
SPIA
Other
Segment by Application
Medical Diagnostic
Scientific Research
Food Testing
Environmental Hygiene
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Isothermal Nucleic Acid Amplification Technology (INAAT) company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 LAMP
1.2.3 TMA
1.2.4 NEAR
1.2.5 NASBA
1.2.6 HDA
1.2.7 SPIA
1.2.8 Other
1.3 Market by Application
1.3.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Diagnostic
1.3.3 Scientific Research
1.3.4 Food Testing
1.3.5 Environmental Hygiene
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Perspective (2020-2031)
2.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Trends by Region
2.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Region (2020-2025)
2.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Region (2026-2031)
2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Dynamics
2.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Trends
2.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
2.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
2.3.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue
3.1.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue (2020-2025)
3.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Players (2020-2025)
3.2 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue
3.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio
3.4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2024
3.5 Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT) Head office and Area Served
3.6 Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Product and Application
3.7 Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Type
4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Type (2020-2025)
4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2026-2031)
5 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Application
5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Application (2020-2025)
5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
6.4 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
7.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
8.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025)
8.4 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
9.2 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
9.4 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
10.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
10.4 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.1.4 Abbott Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 BioMerieux
11.2.1 BioMerieux Company Details
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.2.4 BioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.2.5 BioMerieux Recent Development
11.3 Hologic
11.3.1 Hologic Company Details
11.3.2 Hologic Business Overview
11.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.3.4 Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.3.5 Hologic Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.4.4 BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.4.5 BD Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.5.4 Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.5.5 Grifols Recent Development
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.6.4 Quidel Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.6.5 Quidel Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.7.4 Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.7.5 Meridian Bioscience Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.8.4 Qiagen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.8.5 Qiagen Recent Development
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Details
11.9.2 Eiken Chemical Business Overview
11.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.9.4 Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.9.5 Eiken Chemical Recent Development
11.10 OptiGene
11.10.1 OptiGene Company Details
11.10.2 OptiGene Business Overview
11.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.10.4 OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.10.5 OptiGene Recent Development
11.11 HiberGene Diagnostic
11.11.1 HiberGene Diagnostic Company Details
11.11.2 HiberGene Diagnostic Business Overview
11.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.11.4 HiberGene Diagnostic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.11.5 HiberGene Diagnostic Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.12.4 Lucigen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.12.5 Lucigen Recent Development
11.13 Nippon Gene
11.13.1 Nippon Gene Company Details
11.13.2 Nippon Gene Business Overview
11.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.13.4 Nippon Gene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.13.5 Nippon Gene Recent Development
11.14 Mast Group
11.14.1 Mast Group Company Details
11.14.2 Mast Group Business Overview
11.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.14.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.14.5 Mast Group Recent Development
11.15 New England Biolabs
11.15.1 New England Biolabs Company Details
11.15.2 New England Biolabs Business Overview
11.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.15.4 New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.15.5 New England Biolabs Recent Development
11.16 Ustar Biotechnologies
11.16.1 Ustar Biotechnologies Company Details
11.16.2 Ustar Biotechnologies Business Overview
11.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.16.4 Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.16.5 Ustar Biotechnologies Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Details
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.17.4 Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 MeG Biotech
11.18.1 MeG Biotech Company Details
11.18.2 MeG Biotech Business Overview
11.18.3 MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.18.4 MeG Biotech Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.18.5 MeG Biotech Recent Development
11.19 BioLabs
11.19.1 BioLabs Company Details
11.19.2 BioLabs Business Overview
11.19.3 BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.19.4 BioLabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.19.5 BioLabs Recent Development
11.20 Mast Group
11.20.1 Mast Group Company Details
11.20.2 Mast Group Business Overview
11.20.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.20.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.20.5 Mast Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 LAMP
1.2.3 TMA
1.2.4 NEAR
1.2.5 NASBA
1.2.6 HDA
1.2.7 SPIA
1.2.8 Other
1.3 Market by Application
1.3.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Medical Diagnostic
1.3.3 Scientific Research
1.3.4 Food Testing
1.3.5 Environmental Hygiene
1.3.6 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Perspective (2020-2031)
2.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Growth Trends by Region
2.2.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Region (2020-2025)
2.2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Region (2026-2031)
2.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Dynamics
2.3.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Industry Trends
2.3.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
2.3.3 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
2.3.4 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue
3.1.1 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Revenue (2020-2025)
3.1.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Players (2020-2025)
3.2 Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue
3.4 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio
3.4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2024
3.5 Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT) Head office and Area Served
3.6 Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Product and Application
3.7 Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Type
4.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Type (2020-2025)
4.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2026-2031)
5 Isothermal Nucleic Acid Amplification Technology (INAAT) Breakdown Data by Application
5.1 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Historic Market Size by Application (2020-2025)
5.2 Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
6.2 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
6.4 North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
7.2 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
7.4 Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
8.2 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025)
8.4 Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
9.2 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
9.4 Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (2020-2031)
10.2 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025)
10.4 Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.1.4 Abbott Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 BioMerieux
11.2.1 BioMerieux Company Details
11.2.2 BioMerieux Business Overview
11.2.3 BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.2.4 BioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.2.5 BioMerieux Recent Development
11.3 Hologic
11.3.1 Hologic Company Details
11.3.2 Hologic Business Overview
11.3.3 Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.3.4 Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.3.5 Hologic Recent Development
11.4 BD
11.4.1 BD Company Details
11.4.2 BD Business Overview
11.4.3 BD Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.4.4 BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.4.5 BD Recent Development
11.5 Grifols
11.5.1 Grifols Company Details
11.5.2 Grifols Business Overview
11.5.3 Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.5.4 Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.5.5 Grifols Recent Development
11.6 Quidel
11.6.1 Quidel Company Details
11.6.2 Quidel Business Overview
11.6.3 Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.6.4 Quidel Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.6.5 Quidel Recent Development
11.7 Meridian Bioscience
11.7.1 Meridian Bioscience Company Details
11.7.2 Meridian Bioscience Business Overview
11.7.3 Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.7.4 Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.7.5 Meridian Bioscience Recent Development
11.8 Qiagen
11.8.1 Qiagen Company Details
11.8.2 Qiagen Business Overview
11.8.3 Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.8.4 Qiagen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.8.5 Qiagen Recent Development
11.9 Eiken Chemical
11.9.1 Eiken Chemical Company Details
11.9.2 Eiken Chemical Business Overview
11.9.3 Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.9.4 Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.9.5 Eiken Chemical Recent Development
11.10 OptiGene
11.10.1 OptiGene Company Details
11.10.2 OptiGene Business Overview
11.10.3 OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.10.4 OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.10.5 OptiGene Recent Development
11.11 HiberGene Diagnostic
11.11.1 HiberGene Diagnostic Company Details
11.11.2 HiberGene Diagnostic Business Overview
11.11.3 HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.11.4 HiberGene Diagnostic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.11.5 HiberGene Diagnostic Recent Development
11.12 Lucigen
11.12.1 Lucigen Company Details
11.12.2 Lucigen Business Overview
11.12.3 Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.12.4 Lucigen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.12.5 Lucigen Recent Development
11.13 Nippon Gene
11.13.1 Nippon Gene Company Details
11.13.2 Nippon Gene Business Overview
11.13.3 Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.13.4 Nippon Gene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.13.5 Nippon Gene Recent Development
11.14 Mast Group
11.14.1 Mast Group Company Details
11.14.2 Mast Group Business Overview
11.14.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.14.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.14.5 Mast Group Recent Development
11.15 New England Biolabs
11.15.1 New England Biolabs Company Details
11.15.2 New England Biolabs Business Overview
11.15.3 New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.15.4 New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.15.5 New England Biolabs Recent Development
11.16 Ustar Biotechnologies
11.16.1 Ustar Biotechnologies Company Details
11.16.2 Ustar Biotechnologies Business Overview
11.16.3 Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.16.4 Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.16.5 Ustar Biotechnologies Recent Development
11.17 Thermo Fisher Scientific
11.17.1 Thermo Fisher Scientific Company Details
11.17.2 Thermo Fisher Scientific Business Overview
11.17.3 Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.17.4 Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.17.5 Thermo Fisher Scientific Recent Development
11.18 MeG Biotech
11.18.1 MeG Biotech Company Details
11.18.2 MeG Biotech Business Overview
11.18.3 MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.18.4 MeG Biotech Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.18.5 MeG Biotech Recent Development
11.19 BioLabs
11.19.1 BioLabs Company Details
11.19.2 BioLabs Business Overview
11.19.3 BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.19.4 BioLabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.19.5 BioLabs Recent Development
11.20 Mast Group
11.20.1 Mast Group Company Details
11.20.2 Mast Group Business Overview
11.20.3 Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Introduction
11.20.4 Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
11.20.5 Mast Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of LAMP
Table 3. Key Players of TMA
Table 4. Key Players of NEAR
Table 5. Key Players of NASBA
Table 6. Key Players of HDA
Table 7. Key Players of SPIA
Table 8. Key Players of Other
Table 9. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region (2020-2025)
Table 13. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region (2026-2031)
Table 15. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends
Table 16. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
Table 17. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
Table 18. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
Table 19. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Players (2020-2025)
Table 21. Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) as of 2024)
Table 22. Ranking of Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Headquarters and Area Served
Table 25. Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Product and Application
Table 26. Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2020-2025)
Table 30. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2026-2031)
Table 32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Application (2020-2025)
Table 34. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Application (2026-2031)
Table 36. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 54. Abbott Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. BioMerieux Company Details
Table 57. BioMerieux Business Overview
Table 58. BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 59. BioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 60. BioMerieux Recent Development
Table 61. Hologic Company Details
Table 62. Hologic Business Overview
Table 63. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 64. Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 65. Hologic Recent Development
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 69. BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 70. BD Recent Development
Table 71. Grifols Company Details
Table 72. Grifols Business Overview
Table 73. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 74. Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 75. Grifols Recent Development
Table 76. Quidel Company Details
Table 77. Quidel Business Overview
Table 78. Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 79. Quidel Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 80. Quidel Recent Development
Table 81. Meridian Bioscience Company Details
Table 82. Meridian Bioscience Business Overview
Table 83. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 84. Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 85. Meridian Bioscience Recent Development
Table 86. Qiagen Company Details
Table 87. Qiagen Business Overview
Table 88. Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 89. Qiagen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 90. Qiagen Recent Development
Table 91. Eiken Chemical Company Details
Table 92. Eiken Chemical Business Overview
Table 93. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 94. Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 95. Eiken Chemical Recent Development
Table 96. OptiGene Company Details
Table 97. OptiGene Business Overview
Table 98. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 99. OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 100. OptiGene Recent Development
Table 101. HiberGene Diagnostic Company Details
Table 102. HiberGene Diagnostic Business Overview
Table 103. HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 104. HiberGene Diagnostic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 105. HiberGene Diagnostic Recent Development
Table 106. Lucigen Company Details
Table 107. Lucigen Business Overview
Table 108. Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 109. Lucigen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 110. Lucigen Recent Development
Table 111. Nippon Gene Company Details
Table 112. Nippon Gene Business Overview
Table 113. Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 114. Nippon Gene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 115. Nippon Gene Recent Development
Table 116. Mast Group Company Details
Table 117. Mast Group Business Overview
Table 118. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 119. Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 120. Mast Group Recent Development
Table 121. New England Biolabs Company Details
Table 122. New England Biolabs Business Overview
Table 123. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 124. New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 125. New England Biolabs Recent Development
Table 126. Ustar Biotechnologies Company Details
Table 127. Ustar Biotechnologies Business Overview
Table 128. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 129. Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 130. Ustar Biotechnologies Recent Development
Table 131. Thermo Fisher Scientific Company Details
Table 132. Thermo Fisher Scientific Business Overview
Table 133. Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 134. Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 135. Thermo Fisher Scientific Recent Development
Table 136. MeG Biotech Company Details
Table 137. MeG Biotech Business Overview
Table 138. MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 139. MeG Biotech Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 140. MeG Biotech Recent Development
Table 141. BioLabs Company Details
Table 142. BioLabs Business Overview
Table 143. BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 144. BioLabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 145. BioLabs Recent Development
Table 146. Mast Group Company Details
Table 147. Mast Group Business Overview
Table 148. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 149. Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 150. Mast Group Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Isothermal Nucleic Acid Amplification Technology (INAAT) Picture
Figure 2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type: 2024 VS 2031
Figure 4. LAMP Features
Figure 5. TMA Features
Figure 6. NEAR Features
Figure 7. NASBA Features
Figure 8. HDA Features
Figure 9. SPIA Features
Figure 10. Other Features
Figure 11. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application: 2024 VS 2031
Figure 13. Medical Diagnostic Case Studies
Figure 14. Scientific Research Case Studies
Figure 15. Food Testing Case Studies
Figure 16. Environmental Hygiene Case Studies
Figure 17. Other Case Studies
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT) Report Years Considered
Figure 19. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region: 2024 VS 2031
Figure 22. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Players in 2024
Figure 23. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. The Top 10 and 5 Players Market Share by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2024
Figure 25. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 27. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 31. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region (2020-2031)
Figure 39. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 47. Mexico Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 51. Turkey Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Abbott Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 55. BioMerieux Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 56. Hologic Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 57. BD Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 58. Grifols Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 59. Quidel Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 60. Meridian Bioscience Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 61. Qiagen Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 62. Eiken Chemical Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 63. OptiGene Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 64. HiberGene Diagnostic Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 65. Lucigen Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 66. Nippon Gene Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 67. Mast Group Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 68. New England Biolabs Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 69. Ustar Biotechnologies Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 70. Thermo Fisher Scientific Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 71. MeG Biotech Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 72. BioLabs Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 73. Mast Group Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Table 1. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of LAMP
Table 3. Key Players of TMA
Table 4. Key Players of NEAR
Table 5. Key Players of NASBA
Table 6. Key Players of HDA
Table 7. Key Players of SPIA
Table 8. Key Players of Other
Table 9. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 11. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025) & (US$ Million)
Table 12. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region (2020-2025)
Table 13. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 14. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region (2026-2031)
Table 15. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends
Table 16. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Drivers
Table 17. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Challenges
Table 18. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Restraints
Table 19. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue by Players (2020-2025) & (US$ Million)
Table 20. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Players (2020-2025)
Table 21. Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) as of 2024)
Table 22. Ranking of Global Top Isothermal Nucleic Acid Amplification Technology (INAAT) Companies by Revenue (US$ Million) in 2024
Table 23. Global 5 Largest Players Market Share by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue (CR5 and HHI) & (2020-2025)
Table 24. Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Headquarters and Area Served
Table 25. Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Product and Application
Table 26. Global Key Players of Isothermal Nucleic Acid Amplification Technology (INAAT), Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Type (2020-2025) & (US$ Million)
Table 29. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2020-2025)
Table 30. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 31. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Type (2026-2031)
Table 32. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2025) & (US$ Million)
Table 33. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Application (2020-2025)
Table 34. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 35. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue Market Share by Application (2026-2031)
Table 36. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 38. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 39. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 40. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 41. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 42. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 43. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2020-2025) & (US$ Million)
Table 44. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Region (2026-2031) & (US$ Million)
Table 45. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 47. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 48. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 49. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2020-2025) & (US$ Million)
Table 50. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Country (2026-2031) & (US$ Million)
Table 51. Abbott Company Details
Table 52. Abbott Business Overview
Table 53. Abbott Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 54. Abbott Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 55. Abbott Recent Development
Table 56. BioMerieux Company Details
Table 57. BioMerieux Business Overview
Table 58. BioMerieux Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 59. BioMerieux Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 60. BioMerieux Recent Development
Table 61. Hologic Company Details
Table 62. Hologic Business Overview
Table 63. Hologic Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 64. Hologic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 65. Hologic Recent Development
Table 66. BD Company Details
Table 67. BD Business Overview
Table 68. BD Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 69. BD Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 70. BD Recent Development
Table 71. Grifols Company Details
Table 72. Grifols Business Overview
Table 73. Grifols Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 74. Grifols Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 75. Grifols Recent Development
Table 76. Quidel Company Details
Table 77. Quidel Business Overview
Table 78. Quidel Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 79. Quidel Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 80. Quidel Recent Development
Table 81. Meridian Bioscience Company Details
Table 82. Meridian Bioscience Business Overview
Table 83. Meridian Bioscience Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 84. Meridian Bioscience Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 85. Meridian Bioscience Recent Development
Table 86. Qiagen Company Details
Table 87. Qiagen Business Overview
Table 88. Qiagen Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 89. Qiagen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 90. Qiagen Recent Development
Table 91. Eiken Chemical Company Details
Table 92. Eiken Chemical Business Overview
Table 93. Eiken Chemical Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 94. Eiken Chemical Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 95. Eiken Chemical Recent Development
Table 96. OptiGene Company Details
Table 97. OptiGene Business Overview
Table 98. OptiGene Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 99. OptiGene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 100. OptiGene Recent Development
Table 101. HiberGene Diagnostic Company Details
Table 102. HiberGene Diagnostic Business Overview
Table 103. HiberGene Diagnostic Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 104. HiberGene Diagnostic Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 105. HiberGene Diagnostic Recent Development
Table 106. Lucigen Company Details
Table 107. Lucigen Business Overview
Table 108. Lucigen Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 109. Lucigen Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 110. Lucigen Recent Development
Table 111. Nippon Gene Company Details
Table 112. Nippon Gene Business Overview
Table 113. Nippon Gene Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 114. Nippon Gene Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 115. Nippon Gene Recent Development
Table 116. Mast Group Company Details
Table 117. Mast Group Business Overview
Table 118. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 119. Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 120. Mast Group Recent Development
Table 121. New England Biolabs Company Details
Table 122. New England Biolabs Business Overview
Table 123. New England Biolabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 124. New England Biolabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 125. New England Biolabs Recent Development
Table 126. Ustar Biotechnologies Company Details
Table 127. Ustar Biotechnologies Business Overview
Table 128. Ustar Biotechnologies Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 129. Ustar Biotechnologies Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 130. Ustar Biotechnologies Recent Development
Table 131. Thermo Fisher Scientific Company Details
Table 132. Thermo Fisher Scientific Business Overview
Table 133. Thermo Fisher Scientific Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 134. Thermo Fisher Scientific Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 135. Thermo Fisher Scientific Recent Development
Table 136. MeG Biotech Company Details
Table 137. MeG Biotech Business Overview
Table 138. MeG Biotech Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 139. MeG Biotech Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 140. MeG Biotech Recent Development
Table 141. BioLabs Company Details
Table 142. BioLabs Business Overview
Table 143. BioLabs Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 144. BioLabs Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 145. BioLabs Recent Development
Table 146. Mast Group Company Details
Table 147. Mast Group Business Overview
Table 148. Mast Group Isothermal Nucleic Acid Amplification Technology (INAAT) Product
Table 149. Mast Group Revenue in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025) & (US$ Million)
Table 150. Mast Group Recent Development
Table 151. Research Programs/Design for This Report
Table 152. Key Data Information from Secondary Sources
Table 153. Key Data Information from Primary Sources
Table 154. Authors List of This Report
List of Figures
Figure 1. Isothermal Nucleic Acid Amplification Technology (INAAT) Picture
Figure 2. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Type: 2024 VS 2031
Figure 4. LAMP Features
Figure 5. TMA Features
Figure 6. NEAR Features
Figure 7. NASBA Features
Figure 8. HDA Features
Figure 9. SPIA Features
Figure 10. Other Features
Figure 11. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size by Application (2020-2031) & (US$ Million)
Figure 12. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Application: 2024 VS 2031
Figure 13. Medical Diagnostic Case Studies
Figure 14. Scientific Research Case Studies
Figure 15. Food Testing Case Studies
Figure 16. Environmental Hygiene Case Studies
Figure 17. Other Case Studies
Figure 18. Isothermal Nucleic Acid Amplification Technology (INAAT) Report Years Considered
Figure 19. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 20. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 21. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region: 2024 VS 2031
Figure 22. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Players in 2024
Figure 23. Global Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. The Top 10 and 5 Players Market Share by Isothermal Nucleic Acid Amplification Technology (INAAT) Revenue in 2024
Figure 25. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. North America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 27. United States Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Canada Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Europe Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 31. Germany Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. France Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. U.K. Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Italy Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Russia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Nordic Countries Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Region (2020-2031)
Figure 39. China Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Japan Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. South Korea Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Southeast Asia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. India Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Australia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Latin America Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 47. Mexico Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Brazil Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Middle East & Africa Isothermal Nucleic Acid Amplification Technology (INAAT) Market Share by Country (2020-2031)
Figure 51. Turkey Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Saudi Arabia Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 53. UAE Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 54. Abbott Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 55. BioMerieux Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 56. Hologic Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 57. BD Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 58. Grifols Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 59. Quidel Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 60. Meridian Bioscience Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 61. Qiagen Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 62. Eiken Chemical Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 63. OptiGene Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 64. HiberGene Diagnostic Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 65. Lucigen Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 66. Nippon Gene Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 67. Mast Group Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 68. New England Biolabs Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 69. Ustar Biotechnologies Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 70. Thermo Fisher Scientific Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 71. MeG Biotech Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 72. BioLabs Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 73. Mast Group Revenue Growth Rate in Isothermal Nucleic Acid Amplification Technology (INAAT) Business (2020-2025)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Circuit Simulator Market Research Report 2025
Mar 11, 25
Global Schematic Editor Market Research Report 2025
Mar 11, 25
Global Milk Green Tea Market Research Report 2025
Mar 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232